Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) Trial
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the blood pressure lowering efficacy of a treatment
regimen based on a dihydropyridine calcium-channel blocker combined with an angiotensin II
type-1 receptor blocker with the recommended treatment regimen based on a low-dose thiazide
diuretic combined with a beta-blocker.
Phase:
Phase 4
Details
Lead Sponsor:
Katholieke Universiteit Leuven KU Leuven
Collaborators:
Hospital Aristide Le Dantec, Dakar, Senegal Institute of Cardiology Abidjan University of Ilorin Teaching Hospital University of Kinshasa University of Libreville University of Nigeria, Enugu Campus University of Yaounde Yaounde Central Hospital
Treatments:
Amlodipine Amlodipine, Valsartan Drug Combination Antihypertensive Agents Bisoprolol Hydrochlorothiazide Valsartan